Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study
单位:[1]Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China[2]Shanghai Tumor Hosp, Shanghai, Peoples R China[3]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China[4]China Med Univ, Liaoning Canc Hosp, Canc Hosp, Shenyang, Peoples R China[5]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China江苏省人民医院[6]Beijing Canc Hosp, Beijing, Peoples R China[7]Henan Canc Hosp, Zhengzhou, Peoples R China河南省肿瘤医院[8]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China[9]Hosp Mae de Deus Ctr, Inst Canc, Petropolis, RS, Brazil[10]China Med Univ, Hosp 1, Shenyang, Peoples R China[11]Inst Canc Estado Sao Paulo, Sao Paulo, Brazil[12]Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China[13]Chinese Peoples Liberat Army, Joint Logist Support Force, Hosp 900, Nanjing, Peoples R China[14]Jilin Canc Hosp, Changchun, Peoples R China[15]Hunan Canc Hosp, Changsha, Peoples R China[16]Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China广东省人民医院[17]Zhejiang Canc Hosp, Hangzhou, Peoples R China浙江省肿瘤医院[18]Hu Bei Canc Hosp, Wuhan, Peoples R China[19]Jiangsu Prov Canc Hosp, Nanjing, Peoples R China[20]Clin Pesqe & Ctr Estudos Oncol Ginecol & Mamaria, Sao Paulo, Brazil[21]HCG Hosp & Kidwai Mem Inst Oncol, Bangalore, Karnataka, India[22]Dr BL Kapur Super Special Hosp, New Delhi, India[23]Tata Mem Hosp, Mumbai, Maharashtra, India[24]Wuhan Union Hosp, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[25]Hosp Base, Fac Med Sao Jose Rio Preto, Sao Paulo, Brazil[26]Med Superspecialty Hosp, Kolkata, India[27]Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Nanjing, Peoples R China[28]Zhejiang Med Univ, Affiliate Hosp 2, Hangzhou, Peoples R China[29]Eastleigh Breast Care Ctr, Pretoria, South Africa[30]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China[31]Bengbu Med Coll, Affiliated Hosp, Bengbu, Peoples R China[32]Hosp Caridade Ijui, Ijui, Brazil[33]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China中山大学附属第二医院[34]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[35]Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Peoples R China[36]Barretos Canc Hosp, Barretos, Brazil[37]Wu Han Tongji Hosp, Wuhan, Peoples R China华中科技大学同济医学院附属同济医院[38]MS Ramaiah Clin Res Ctr, Bangalore, India[39]Gujarat Canc Res Inst, Civil Hosp Campus, Ahmadabad, Gujarat, India[40]Christian Med Coll & Hosp, Ludhiana, Punjab, India[41]Jehangir Hosp, Pune, Maharashtra, India[42]Fujian Prov Canc Hosp, Fuzhou, Peoples R China[43]Med Oncol Ctr Rosebank, Johannesburg, South Africa[44]Sandton Oncol Ctr, Johannesburg, South Africa[45]Shanghai First Peoples Hosp, Shanghai, Peoples R China[46]Eli Lilly & Co, Shanghai, Peoples R China
第一作者单位:[1]Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Jiang Zefei,Hu Xichun,Zhang Qingyuan,et al.Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study[J].CANCER RESEARCH.2021,81(4):
APA:
Jiang, Zefei,Hu, Xichun,Zhang, Qingyuan,Sun, Tao,Yin, Yongmei...&Zhang, Wanli.(2021).Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study.CANCER RESEARCH,81,(4)
MLA:
Jiang, Zefei,et al."Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study".CANCER RESEARCH 81..4(2021)